In Infuse Partners' Q1 2023 letter, Axon Enterprise (AXON, Financial) was highlighted as a key portfolio holding due to its innovative approach to public safety technology and its strong market position. The fund, managed by Ryan Reeves, emphasized Axon's commitment to reducing police-related deaths and its diversified product offerings, which include Tasers, body-worn cameras, and cloud-based evidence management systems.
"Axon is a perfect example of a company with the qualitative characteristics that I look for. A dominant position in a large market, incredible economics, a founder at the helm, a good chunk of recurring revenue, a strong and growing competitive advantage, and a strong preference to internally innovate." — Ryan Reeves, Infuse Partners, Q1 2023 Fund Letter
Read full letter at gurufocus Infuse Partners 2023 Q1 page.